Having established that DMF and 4-OI potently inhibit type I IFN- and TF-mediated thrombin generation in vivo following bacterial infection, we next assessed the broader anticoagulant effects of these compounds in a model of viral-induced coagulopathy. Here, TF is linked to bacterial infectious disease.